Elevated Inflammatory Markers in a Group of Amyotrophic Lateral Sclerosis Patients from Northern India

Overview

Journal Neurochem Res

Specialties Chemistry
Neurology

Date 2008 Feb 5

PMID 18246426

Citations 46

Authors

G Nagesh Babu

Alok Kumar

Ramesh Chandra

S K Puri

Jayantee Kalita

U K Misra

Affiliations

Soon will be listed here.

Abstract

The role of cytokines in the pathophysiology of amyotrophic lateral sclerosis (ALS) and its relation to clinical outcome has not been clearly defined. We evaluated tumor necrosis factor-alpha (TNF-alpha), interferon-gamma (IFN-gamma) and nitric oxide (NO) levels in the serum of 22 ALS patients and 20 controls. Serum TNF-alpha levels and IFN-gamma levels were significantly (P < 0.001) elevated in ALS patients. We also observed NO levels to be significantly (P < 0.05) increased with respect to normal subjects. We further noticed positive correlation between the duration of ALS and these proinflammatory molecule levels. Exitotoxicity and oxidative stress are known to play a crucial role in the neurodegeneration observed in ALS. Since high levels of TNF-alpha are known to be cytotoxic, it could be that a complex interplay of these effectors may be one of the factors underlying the progression of ALS. This study confirms the involvement of inflammation in ALS and the need to develop surrogate markers to check the progression of this disease.

Citing Articles

Melatonin, an Antitumor Necrosis Factor Therapy.

Alvarez-Lopez A, Cruz-Chamorro I, Lardone P, Bejarano I, Aspiazu-Hinostroza K, Ponce-Espana E J Pineal Res. 2024; 77(1):e70025.

PMID: 39740227 PMC: 11685806. DOI: 10.1111/jpi.70025.

ATH-1105, a small-molecule positive modulator of the neurotrophic HGF system, is neuroprotective, preserves neuromotor function, and extends survival in preclinical models of ALS.

Berthiaume A, Reda S, Kleist K, Setti S, Wu W, Johnston J Front Neurosci. 2024; 18:1348157.

PMID: 38389786 PMC: 10881713. DOI: 10.3389/fnins.2024.1348157.

Guggulsterone Selectively Modulates STAT-3, mTOR, and PPAR-Gamma Signaling in a Methylmercury-Exposed Experimental Neurotoxicity: Evidence from CSF, Blood Plasma, and Brain Samples.

Kumar S, Mehan S, Khan Z, Gupta G, Narula A Mol Neurobiol. 2024; 61(8):5161-5193.

PMID: 38170440 DOI: 10.1007/s12035-023-03902-x.

Brain-Gut-Microbiota Axis in Amyotrophic Lateral Sclerosis: A Historical Overview and Future Directions.

Chen S, Cai X, Lao L, Wang Y, Su H, Sun H Aging Dis. 2023; 15(1):74-95.

PMID: 37307822 PMC: 10796086. DOI: 10.14336/AD.2023.0524.

Distinct Plasma Immune Profile in ALS Implicates sTNFR-II in pAMPK/Leptin Homeostasis.

Picher-Martel V, Boutej H, Vezina A, Cordeau P, Kaneb H, Julien J Int J Mol Sci. 2023; 24(6).

PMID: 36982140 PMC: 10049559. DOI: 10.3390/ijms24065065.

References

Babu G, Bawari M, Mathur V, Kalita J, Misra U . Blood glutamate levels in patients with motor neuron disease. Clin Chim Acta. 1998; 273(2):195-200. DOI: 10.1016/s0009-8981(98)00039-4. View

Oygur N, Sonmez O, Saka O, Yegin O . Predictive value of plasma and cerebrospinal fluid tumour necrosis factor-alpha and interleukin-1 beta concentrations on outcome of full term infants with hypoxic-ischaemic encephalopathy. Arch Dis Child Fetal Neonatal Ed. 1999; 79(3):F190-3. PMC: 1720860. DOI: 10.1136/fn.79.3.f190. View

Poloni M, Facchetti D, Mai R, Micheli A, Agnoletti L, Francolini G . Circulating levels of tumour necrosis factor-alpha and its soluble receptors are increased in the blood of patients with amyotrophic lateral sclerosis. Neurosci Lett. 2000; 287(3):211-4. DOI: 10.1016/s0304-3940(00)01177-0. View

Green L, Wagner D, Glogowski J, Skipper P, Wishnok J, Tannenbaum S . Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem. 1982; 126(1):131-8. DOI: 10.1016/0003-2697(82)90118-x. View

Holmoy T, Roos P, Kvale E . ALS: cytokine profile in cerebrospinal fluid T-cell clones. Amyotroph Lateral Scler. 2006; 7(3):183-6. DOI: 10.1080/17482960600664730. View

Silveira R, Procianoy R . Interleukin-6 and tumor necrosis factor-alpha levels in plasma and cerebrospinal fluid of term newborn infants with hypoxic-ischemic encephalopathy. J Pediatr. 2003; 143(5):625-9. DOI: 10.1067/S0022-3476(03)00531-6. View

Moreau C, Devos D, Brunaud-Danel V, Defebvre L, Perez T, Destee A . Elevated IL-6 and TNF-alpha levels in patients with ALS: inflammation or hypoxia?. Neurology. 2005; 65(12):1958-60. DOI: 10.1212/01.wnl.0000188907.97339.76. View

Rhodes P, Leone A, Francis P, Struthers A, Moncada S, Rhodes PM corrected to Rhodes P . The L-arginine:nitric oxide pathway is the major source of plasma nitrite in fasted humans. Biochem Biophys Res Commun. 1995; 209(2):590-6. DOI: 10.1006/bbrc.1995.1541. View

Moser M, Murphy K . Dendritic cell regulation of TH1-TH2 development. Nat Immunol. 2001; 1(3):199-205. DOI: 10.1038/79734. View

10.

Lee S, Dickson D, Liu W, Brosnan C . Induction of nitric oxide synthase activity in human astrocytes by interleukin-1 beta and interferon-gamma. J Neuroimmunol. 1993; 46(1-2):19-24. DOI: 10.1016/0165-5728(93)90229-r. View

11.

Czlonkowska A, Ciesielska A, Gromadzka G, Kurkowska-Jastrzebska I . Estrogen and cytokines production - the possible cause of gender differences in neurological diseases. Curr Pharm Des. 2005; 11(8):1017-30. DOI: 10.2174/1381612053381693. View

12.

Tandan R, Bradley W . Amyotrophic lateral sclerosis: Part 1. Clinical features, pathology, and ethical issues in management. Ann Neurol. 1985; 18(3):271-80. DOI: 10.1002/ana.410180302. View

13.

Taskiran D, Sagduyu A, Yuceyar N, Kutay F, Pogun S . Increased cerebrospinal fluid and serum nitrite and nitrate levels in amyotrophic lateral sclerosis. Int J Neurosci. 2000; 101(1-4):65-72. DOI: 10.3109/00207450008986493. View

14.

NORRIS Jr F, Calanchini P, Fallat R, Panchari S, JEWETT B . The administration of guanidine in amyotrophic lateral sclerosis. Neurology. 1974; 24(8):721-8. DOI: 10.1212/wnl.24.8.721. View

15.

Salter M, Duffy C, Garthwaite J, Strijbos P . Ex vivo measurement of brain tissue nitrite and nitrate accurately reflects nitric oxide synthase activity in vivo. J Neurochem. 1996; 66(4):1683-90. DOI: 10.1046/j.1471-4159.1996.66041683.x. View

16.

Tandan R, Bradley W . Amyotrophic lateral sclerosis: Part 2. Etiopathogenesis. Ann Neurol. 1985; 18(4):419-31. DOI: 10.1002/ana.410180402. View

17.

Brooks B . El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases.... J Neurol Sci. 1994; 124 Suppl:96-107. DOI: 10.1016/0022-510x(94)90191-0. View

18.

Gupta R, Milatovic D, Dettbarn W . Involvement of nitric oxide in myotoxicity produced by diisopropylphosphorofluoridate (DFP)-induced muscle hyperactivity. Arch Toxicol. 2002; 76(12):715-26. DOI: 10.1007/s00204-002-0400-4. View

19.

Jensen M, Hegelund I, Lomholt N, Finsen B, Owens T . IFNgamma enhances microglial reactions to hippocampal axonal degeneration. J Neurosci. 2000; 20(10):3612-21. PMC: 6772678. View

20.

OBrien R, Fischbach G . Modulation of embryonic chick motoneuron glutamate sensitivity by interneurons and agonists. J Neurosci. 1986; 6(11):3290-6. PMC: 6568502. View